Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-FAPI PET/CT in Inflammatory Bowel Disease
NCT04507932Phase 1Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2020
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 68Ga-FAPI in inflammatory bowel disease (IBD), sponsored by Peking Union Medical College Hospital. Primary endpoint: Diagnostic value at 1 year. Status: unknown.
02
Drugs
68Ga-FAPI
03
Conditions
inflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NCT04507932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04507932.